Maternal-fetal medicine is already a complex clinical area, but few challenges are as formidable as diagnosing rare conditions that present like common disorders. Atypical hemolytic uremic syndrome (aHUS) is one such condition, carrying significant risks for both the pregnant patient and the fetus. Yet for many clinicians, it remains difficult to recognize in practice, often masked by overlapping features with more familiar pregnancy-related complications, resulting in a gap between what happens in real-world practice and what can be achieved with current science.

Together with the American College of Osteopathic Obstetricians and Gynecologists (ACOOG), our team has developed an educational initiative focused on improving the identification and management of aHUS in pregnancy and postpartum: "Optimizing Identification and Management of aHUS in Pregnancy and Postpartum."

A Rare Condition With High Stakes

aHUS may be uncommon, but its impact is profound. Pregnancy and the postpartum period are recognized triggers for complement-mediated thrombotic microangiopathy, with patients presenting with hemolysis, thrombocytopenia, and acute kidney injury. Left unrecognized or misdiagnosed, aHUS can progress rapidly, leading to severe maternal complications, including kidney failure, and poor fetal outcomes. In some cases, delayed or inappropriate treatment can have life-threatening consequences.

At the center of aHUS is dysregulation of the complement system. Pregnancy-related stressors can trigger uncontrolled activation of the alternative complement pathway in susceptible individuals, leading to endothelial injury and widespread microvascular damage. While this biology is increasingly well understood, it is not yet consistently translated into clinical recognition. For many clinicians, the challenge lies in applying mechanistic insight to complex, time-sensitive clinical scenarios.

Bridging the Gap Between Knowledge and Action

Our program is designed to help clinicians move along the continuum from understanding to application. Through a series of concise, case-based podcast episodes, learners are guided through the mechanistic drivers of complement-mediated disease, diagnostic strategies to differentiate aHUS, and evidence-based therapeutic approaches, including complement inhibitors.

Given the complexity and urgency of the condition, optimal care requires coordination across specialties as well, including obstetrics, maternal-fetal medicine, hematology, nephrology, and beyond. Early specialist involvement and structured collaboration can significantly improve both diagnostic timelines and patient outcomes. Multidisciplinary collaboration is essential, and this program emphasizes practical strategies for building and engaging care teams, helping clinicians move from reactive consultation to proactive coordination.

As the understanding of complement-mediated disorders continues to evolve, so too must the education that supports clinicians in applying this knowledge. For conditions like aHUS, where early recognition and timely intervention can mean the difference between recovery and severe morbidity, the stakes are especially high. However, by equipping clinicians with the resources to recognize, differentiate, and manage this complex condition, we take a big step toward improving care for pregnant patients.